Cryo-Cell sets Oct. 27, 2026 shareholder meeting

Cryo-Cell International set October 27, 2026 for its 2026 annual meeting, with a September 21, 2026 record date and already-lapsed proposal and nomination deadlines.

Available on EDGAR 09/14/2026 - 04:35 PM EDT Accepted by SEC EDGAR 09/14/2026 - 04:30 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Cryo-Cell International, Inc. (CCEL) announced the schedule for its 2026 Annual Meeting of Stockholders. The Board of Directors set October 27, 2026 as the meeting date and September 21, 2026 as the record date for determining which stockholders are entitled to receive notice of and vote at the meeting.

The company also noted that, under its Bylaws, the deadlines for stockholders to submit proposals of business or director nominations for consideration at the 2026 Annual Meeting were both July 27, 2026. These deadlines have already passed.

8-K Event Classification

Item 8.01 — Other Events

1 item

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Key Figures

2026 Annual Meeting date: October 27, 2026 Record date for voting: September 21, 2026 Deadline for stockholder proposals: July 27, 2026 +2 more

5 metrics

2026 Annual Meeting date October 27, 2026 Date fixed by the Board of Directors for the 2026 Annual Meeting of Stockholders

Record date for voting September 21, 2026 Date for determining stockholders entitled to notice of and to vote at the Annual Meeting

Deadline for stockholder proposals July 27, 2026 Bylaw deadline to provide timely notice of business proposed for the 2026 Annual Meeting

Deadline for director nominations July 27, 2026 Bylaw deadline to provide timely notice of director nominations for the 2026 Annual Meeting

Bylaws filing date December 11, 2018 Date of filing that includes the company’s amended Bylaws as Exhibit 3.1

Key Terms

Record date, Annual Meeting of Stockholders, Bylaws, director nominations

4 terms

Record date regulatory

"has fixed September 21, 2026 as the record date for determining stockholders"

The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.

Annual Meeting of Stockholders regulatory

"date for the 2026 Annual Meeting of Stockholders of the Company"

Bylaws regulatory

"Pursuant to Article II, Section 3 of the Company’s Bylaws"

Corporate bylaws are a company's internal rulebook that explains how the business is run day to day — who makes decisions, how directors and officers are chosen, how shareholder meetings are conducted, and procedures for changes or conflicts. For investors, bylaws matter because they shape governance and control, influence how quickly and easily leadership or strategy can change, and can protect or limit shareholder rights much like house rules affect how a household operates.

director nominations regulatory

"deadline for stockholders to provide timely notice of director nominations"

Director nominations are proposals to appoint specific people to a company's board of directors, put forward for shareholder consideration and typically decided by a vote. The board steers strategy, hires and evaluates executives, and watches over risk and finances—like choosing a school's board or a homeowners’ association—so who is nominated affects governance quality, company direction, and ultimately potential investor returns.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Cryo-Cell International (CCEL) holding its 2026 Annual Meeting of Stockholders?

The 2026 Annual Meeting of Stockholders is scheduled for October 27, 2026. The Board of Directors fixed this date for the annual meeting where eligible stockholders may vote on matters properly brought before the meeting.

What is the record date for voting at Cryo-Cell International’s 2026 Annual Meeting?

The record date is September 21, 2026. Stockholders of record as of the close of business on that date are entitled to receive notice of and vote at the 2026 Annual Meeting of Stockholders.

Can Cryo-Cell International (CCEL) stockholders still submit proposals for the 2026 Annual Meeting?

No. Under the company’s Bylaws, the deadline to provide timely notice of business to be brought before the 2026 Annual Meeting was July 27, 2026, which has already passed.

Are director nominations for Cryo-Cell International’s 2026 Annual Meeting still being accepted?

No. The deadline under Article II, Section 10 of the Bylaws to submit director nominations for consideration at the 2026 Annual Meeting was July 27, 2026, and that date has passed.

Where can investors find Cryo-Cell International’s current Bylaws?

A copy of the company’s Bylaws, as amended, is included as Exhibit 3.1 to a prior filing made on December 11, 2018. That exhibit contains the provisions governing meeting procedures and deadlines.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

false000086269200008626922026-09-102026-09-10

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 10, 2026

CRYO-CELL INTERNATIONAL, INC.

(Exact name of Registrant as Specified in Its Charter)

Delaware			001-40767	22-3023093
(State or Other Jurisdiction of Incorporation)			(Commission File Number)	(IRS Employer Identification No.)
700 Brooker Creek Blvd. Suite 1800
Oldsmar, Florida				34677
(Address of Principal Executive Offices)				(Zip Code)

Registrant’s Telephone Number, Including Area Code: 813 749-2100

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.01 par value		CCEL		NYSE American LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events.

The Board of Directors of the Company has fixed October 27, 2026 as the date for the 2026 Annual Meeting of Stockholders of the Company (the “Annual Meeting”), and has fixed September 21, 2026 as the record date for determining stockholders entitled to notice of and to vote at the Annual Meeting.

Pursuant to Article II, Section 3 of the Company’s Bylaws, the deadline for stockholders to provide timely notice of business proposed to be brought before the Annual Meeting was July 27, 2026. Pursuant to Article II, Section 10 of the Company’s Bylaws, the deadline for stockholders to provide timely notice of director nominations for consideration at the Annual Meeting was also July 27, 2026.

A copy of the Company’s Bylaws, as amended, is included as Exhibit 3.1 to the Current Report on Form 8-K filed with the United States Securities and Exchange Commission on December 11, 2018.

.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

			Cryo-Cell International, Inc.
Date:	September 14, 2026	By:	/s/ David Portnoy
			David Portnoy, Chairman and Co-CEO

Filing Exhibits & Attachments

1 document

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 24.3 KB